§ Mr. FearnTo ask the Secretary of State for Health if, pursuant to his reply of 19 January,Official Report, column 302, there are to be other costs incurred by his Department associated with the cyclotron at St. Thomas' hospital.
§ Mr. FreemanIn addition to the £6 million grant we are making to the Cyclotron trust, we shall meet up to 60 per cent. of the direct running costs of the cyclotron insofar as they are not met from other sources.
§ Mr. FearnTo ask the Secretary of State for Health, pursuant to his reply 19 January,Official Report, column 302, what research documentation and other sources of information were used by his Department before he approved the grant of £6 million to the Cyclotron trust to reach the understanding that neutron therapy that the Cyclotron can provide, can give relief for the effects of certain cancers.
§ Mr. FreemanWe gave careful consideration to the case presented by the Cyclotron trust, and to a wide range of published material, of which the following are illustrative examples
Catterall, M.: The treatment of malignant salivary gland tumours with fast neutrons. International Journal of Radiation Oncology, Biology, Physics, 7 (1981), 1737–1738;Caterall, M., Blake, P. R. and Rampling, R. P.: Fast neutron treatment as an alternative to radical surgery for malignant tumours of the facial area. British Medical Journal, 289 (1984), 1653–55;Cohen, L., Hendrickson F., Kurup, P. D., et al; Clinical evaluation of neutron therapy: current results and prospects 1983. Cancer, 55 (1985), 10–17;Medical Research Council neutron therapy working group: A comprehensive review of the Hammersmith (1971–75) and Edinburgh (1977–82) neutron therapy trials of certain cancers of the oral cavity, oropharynx, largnx and hypoharynx. Britis Journal of Radiology,59; 701 (1986), 429–440.